Multiply Labs to Bring “Physical AI” Robotics Technology to Advanced Biomanufacturing With NVIDIA

Core Insights - Multiply Labs has achieved a significant milestone in scaling the production of cell and gene therapies by utilizing NVIDIA's open Isaac and GR00T technologies, which include advanced robotics simulation and perception [1] Company Developments - The company is recognized as a leader in robotic biomanufacturing, indicating its strong position in the industry [1] - The adoption of advanced technologies marks a pivotal shift from traditional manual processes to more automated and efficient methods in the production of cell and gene therapies [1] Industry Impact - The integration of robotics in biomanufacturing is expected to transform the cell and gene therapy landscape, which has historically depended on artisanal production methods [1] - Cell and gene therapies are highlighted as life-changing treatments, emphasizing their potential impact on healthcare [1]